The global monoclonal antibody diagnostic reagent market is witnessing rapid expansion, driven by advancements in diagnostic technologies and the rising burden of chronic diseases worldwide. According to market analysis, the industry is projected to grow significantly from US$ 12.82 billion in 2025 to US$ 41.02 billion by 2034 , registering a strong CAGR of 13.79% during the forecast...